HORIZON 2020 - Developing tools for early diagnosis and treatment of Alzheimer's

PANA has set out to develop an innovative method to diagnose Alzheimer's in its early stages, up to five years before the occurrence of clinical symptoms. This could increase the duration and quality of patients' lives considerably.

Related topics

Health Leadership in enabling and industrial technologies Advanced materials Belgium Finland Lithuania Netherlands Portugal Spain

date: 31/01/2017

Project: PROMOTING ACTIVE AGEING: FUNCTIONAL NANO...

acronym: PANA

See also: Project details

Alzheimer’s disease is the leading cause of dementia and loss of autonomy among elderly people today, posing a huge challenge for families, medical professionals and society in general.

There is currently no effective method for early diagnosis of Alzheimer’s, which effectively limits the use of early therapeutic strategies to delay onset of the disease’s most adverse symptoms.